During pregnancy, referral to and/or comanagement with maternal-fetal medicine as indicated—but especially for patients with elevated TSH receptor antibodies, uncontrolled hyperthyroidism, or a history of irradiation for hyperthyroidism on replacement therapy—are key to improving maternal and fetal outcomes. Here, TSHR is linked to hyperthyroidism.